[First clinical experiences with N-(5-nitro-2-furfurylidene)-1-aminohydantoin sodium salt in the obstetrico-gynecological field].
D001472:Bartholin's Glands; D004194:Disease; D005260:Female; D006801:Humans; D006827:Hydantoins; D008413:Mastitis / Q000628:therapy*; D009581:Nitrofurans / Q000628:therapy*; D010538:Peritonitis / Q000150:complications*; D012964:Sodium; D014552:Urinary Tract Infections / Q000628:therapy*
C504350:1-aminohydantoin; D006827:Hydantoins; D009581:Nitrofurans; D012964:Sodium
BARTHOLIN'S GLANDS/diseases; MASTITIS/therapy; NITROFURANS/therapy; PERITONITIS/complications; URINARY TRACT INFECTIONS/therapy